Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predicting Response to Lidocaine in Painful Diabetic Neuropathy
NCT02363803Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2015
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in diabetic neuropathy (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Change in Spontaneous Pain at 60-120 Minutes After Lidocaine Infusion Initiated. Started Feb 2015; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT02363803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02363803.